STJ News 62.49 St. Jude Medical (STJ)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
St. Jude Medical (STJ) 62.49 $STJ

Why Medtronic Is One of the Smartest Companies on the Planet
Leo Sun, The Motley Fool - Motley Fool - Sat Apr 19, 9:00AM CDT
MIT Tech Review recently named Medtronic  one of of the 50 smartest companies of 2013, placing the 65-year-old medical device company side by side with much younger companies like Google , and...

Heart Device Lawsuits Continue Against St. Jude Medical, Inc. Over Defective Riata Lead Wires says The Torkzadeh Law Firm
PR Newswire - Fri Apr 18, 12:44PM CDT
The Torkzadeh Law Firm (TorkLaw) is now representing over 100 clients against St. Jude Medical, Inc. related to the recalled St. Jude Medical, Inc. Riata leads.

Earnings Roundup: St. Jude's 1 Bright Spot
Todd Campbell, The Motley Fool - Motley Fool - Thu Apr 17, 5:30PM CDT
St. Jude 's tepid first-quarter results mask a quickening in sales for the company's atrial fibrillation products that shouldn't be ignored by investors. St. Jude has been boosting its atrial fibrillation, or AF, offering in anticipation of...

Baxter Tops Earnings & Revenues Ests - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Apr 17, 12:10PM CDT
BAX also reiterated its outlook for full year 2014.

Company News for April 17, 2014 - Corporate Summary
Zacks Equity Research - Zacks Investment Research - Thu Apr 17, 9:06AM CDT
Companies in the News are: BAC,IBKR,STJ,ABT

Injunction Lifted on Boston Scientific's Guidezilla - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Apr 16, 5:50PM CDT
Boston Scientific's Guidezilla guide extension catheter gets freed of an injunction by the U.S. Court of Appeals for the Federal Circuit.

St. Jude falls on soft earnings
at Investor's Business Daily - Wed Apr 16, 5:48PM CDT
Device maker St. Jude Medical (STJ) posted Q1 earnings and guidance that modestly beat Wall Street's expectations Wed., but investors were unimpressed as its stock was down nearly 2% to 62.04. EPS climbed 4% to 96 cents due to lower taxes, analysts...

St. Jude Medical Inc.: In-Line Is Just Not Good Enough
Stephen D., Simpson,, The Motley Fool - Motley Fool - Wed Apr 16, 5:30PM CDT
It's hard to call it a bad thing when Wall Street likes a stock, but rising expectations can create problems of their own. St. Jude Medical seems to have done a good job of selling the Street on the idea that it has turned over a new leaf and that...

After Yesterday's Decline of 1.88%, St Jude Medical Offers Investors Better Value
Comtex SmarTrend(R) - Wed Apr 16, 4:51PM CDT
St Jude Medical (NYSE:STJ) traded in a range yesterday that spanned from a low of $59.85 to a high of $63.45. Yesterday, the shares fell 1.9%, which took the trading range below the 3-day low of $61.47 on volume of 5.8 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

St Jude Medical Falls 1.88% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Wed Apr 16, 4:50PM CDT
St Jude Medical (NYSE:STJ) traded in a range yesterday that spanned from a low of $59.85 to a high of $63.45. Yesterday, the shares fell 1.9%, which took the trading range below the 3-day low of $61.47 on volume of 5.8 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

FDA Clears Boston Scientific's Heart Devices - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Apr 16, 2:10PM CDT
Boston Scientific won the U.S. FDA approval for a bunch of defibrillators and heart failure devices.

FDA Nod for Covidien's Kangaroo Feeding Tube - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Apr 16, 2:00PM CDT
Shares of Covidien rose 1.3% since the announcement to close at $69.90 yesterday.

St. Jude Medical (STJ) Stock Down Despite Positive Earnings Report
at The Street - Wed Apr 16, 10:42AM CDT
St. Jude Medical (STJ) tumbles in trading despite beating analysts EPS estimates by 1 cent

St. Jude Medical Earnings In Line, But Stock Falls
at Investor's Business Daily - Wed Apr 16, 10:31AM CDT
Device maker St. Jude Medical (STJ) met Wall Street's expectations with its Q1 results and guidance Wednesday, but the stock was down 3% in morning trading on the stock market today. St. Jude's sales rose 2% over the year-earlier quarter to $1.36...

St. Jude Beats Earnings by a Penny - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Apr 16, 9:24AM CDT
For full year 2014, St. Jude Medical upgraded its revenues guidance to the range of $5,610 to $5,760 million from the prior range of $5,600 million to $5,750 million.

St Jude Medical (STJ) Falls Further As It's Water-Logged And Getting Wetter
at The Street - Wed Apr 16, 9:11AM CDT
Trade-Ideas LLC identified St Jude Medical (STJ) as a "water-logged and getting wetter" (weak stocks crossing below support with today's range greater than 200%) candidate

St. Jude Medical Reports First Quarter 2014 Results
Business Wire - Wed Apr 16, 6:30AM CDT
St. Jude Medical, Inc. (NYSE:STJ) today reported sales and net earnings for the first quarter ended March 29, 2014.

Will St. Jude Medical (STJ) Surprise This Earnings Season? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Apr 15, 3:32PM CDT
Our proven model does not conclusively show that St. Jude Medical is likely to beat earnings this quarter.

Johnson & Johnson's Earnings Report Impresses
Stephen D., Simpson,, The Motley Fool - Motley Fool - Tue Apr 15, 3:28PM CDT
If you're going to have a "messy" quarter, you probably couldn't do it much better than Johnson & Johnson did in the first quarter. Devices and Consumer continue to log disappointing results, but the higher-margin Pharma...

The New Wave in Covidien's Endoscopic Devices - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Apr 15, 2:00PM CDT
Shares of Covidien rose 1.3% in the trading session following the news release and closed at $69.92 yesterday.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Pony.ai & Toyota Launch 1,000 Gen-7 Robotaxis in China

Updated Category News Views 74

Revving Up the Autonomous Ride Revolution Not every day you see two giants, Pony.ai and Toyota, join forces to shake up the way folks get from A to B. But here we are — they’ve fired up their engines in Guangzhou, unleashing their Gen-7 bZ4X Robotaxis for commercial use. And let me tell you, this is no shot in the dark. With plans to dot about 1,000 of these...

Continue Reading
SOBER CAFFEINE™: Modern Energizer Without the Bull

Updated Category News Views 37

Shed the Cans and Embrace Convenience I'm sure you've had a run-in with the standard energy drink routine. You know, the massive cans, a gut punch of sugar, and the inevitable crash that follows? Sobriety Supplements LLC decided enough is enough and rolled out something that just makes sense—SOBER CAFFEINE™ capsules. This little pill is a godsend for folks sick of...

Continue Reading
Ampace Focuses on Battery Safety Standards at RE+ 2026

Updated Category News Views 113

Battery Safety Takes Center Stage No mystery here: the safety of our beloved lithium-ion batteries is crucial, especially as AI data centers sprout like weeds. At RE+ 2026, Ampace is putting its chips on the table by spotlighting this hot topic. Dr. Drew Feng, their Chief Safety Officer, is set to reveal the big guns: findings from the PU100 large-scale fire test. Mark...

Continue Reading
Employment Law Suit Hits ABC: Alleged Wage Violations

Updated Category News Views 275

ABC Under Fire for Labor Code Violations You know it's a rocky road when a company like American Broadcasting Companies, Inc. lands itself in hot water with accusations riding high on labor law violations. People yapping about lunch breaks? Well, that’s the ball game here. Meal and Rest Break Controversies According to a recent lawsuit filed by Blumenthal Nordrehaug...

Continue Reading
FFR's Michigan Milestone and Major Robotics Update

Updated Category News Views 160

Nobody's going to argue that breaking into new territories isn't a gamble, but sometimes you just need to roll the dice. FF EAI Robotics Ecosystem Inc. (NASDAQ: FFR) is banking on their move with Aegis Ultra robots, making an academic splash at Central Michigan University. This isn't just about ticking off another state; it's about stacking the deck with new...

Continue Reading
Viking Ventures: Impacts of VK2735 on Obesity Examined

Updated Category News Views 292

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

Continue Reading
Pan-Mass Challenge Gifts $80M to Dana-Farber for 2026

Updated Category News Views 308

A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 431

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 407

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 421

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading

Top 5 Most Recently Viewed Articles

Daniel Pink on Leadership and Workplace Evolution Insights

Updated Category News Views 424

Exploring Leadership in a Changing Workplace The recent episode of Info-Tech Research Group's podcast, Digital Disruption, highlights a thought-provoking discussion with bestselling author Daniel Pink, focusing on how leaders can adapt in a time he describes as 'the great sort'. This term encapsulates the ongoing transformation in our approach to work, leadership, and the...

Continue Reading
MORSE Corp's Community Cleanup Initiative: Making an Impact

Updated Category News Views 240

MORSE Corp's Commitment to Community Service MORSE Corp recently dedicated an entire day to community service by hosting a cleanup initiative at local beaches and parks. On a beautiful Wednesday, the organization mobilized its team to gather at a coastal spot to improve the environment and promote community spirit. This initiative is part of their annual effort to...

Continue Reading
FDA's New Proposal to Enhance Nutrition Awareness on Food Labels

Updated Category News Views 125

Revolutionizing Nutrition Transparency for Consumers Today, the U.S. Food and Drug Administration (FDA) is taking significant steps towards improving consumer awareness about the nutritional value of packaged foods. A new proposal dictates that most packaged foods will require a prominent front-of-package (FOP) nutrition label. This initiative is part of a broader...

Continue Reading
CW Bancorp Declares Quarterly Dividend for Shareholders

Updated Category News Views 150

CW Bancorp Announces Dividend Declaration CW BANCORP (OTCQX: CWBK), the parent company of CommerceWest Bank, has approved a quarterly cash dividend. The news comes as the company continues to prioritize shareholder value while supporting its growth journey. Details of the Cash Dividend The Board of Directors of CW Bancorp declared a cash dividend of $0.23 per common...

Continue Reading
Universal Electronics Unveils QuickSet homeSense at CES Event

Updated Category News Views 348

Universal Electronics Introduces QuickSet homeSense Technology Universal Electronics Inc. (NASDAQ: UEIC) has made headlines by launching its innovative QuickSet homeSense technology. This introduction took place at the prestigious International Consumer Electronics Show (CES) where the spotlight is often on groundbreaking tech. UEI, a leader in wireless control solutions,...

Continue Reading